Add-on to 1-3 oral anti-hyperglycemic agents (metformin, sulfonylurea, or SGLT-2 inhibitor) SURPASS-4 (NCT03730662) was a 104-week open-label trial (52-week primary endpoint) that randomized 2002 adult patients with type 2 diabetes mellitus with increased cardiovascular risk to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or insulin glargine 100 units/mL once daily (1:1:1:3 ratio) on a background of metformin (95%) and/or sulfonylureas (54%) and/or SGLT2 inhibitors (25%)
That said, there is nothing wrong with asking whether peptide therapy could play a supporting role in your overall plan
Draw 2mL of sterile water and inject it slowly down the side of the vial, not onto the powder
Weve Got Answers Stepping into the world of B12 injections for the first time can feel a bit daunting
TIER 1 (10.6mg total) $275 total for 10 week supply Monthly cost breakdown: $110 Recommended if new to treatment or for those on 0.2-1mg/week TIER 2 (15.9mg total) $330 total for 10 week supply Monthly cost breakdown: $132 Recommended for those on 1.1-1.5mg/week TIER 3 (21.2mg total) $430 total for 8-10 week supply Monthly cost breakdown: $172-$215 based on weekly dose Recommended for those on 1.6mg/week and up Custom Liraglutide Treatment Plans Our partner pharmacies expertly prepare custom-compounded Liraglutide injectables to help support your personalized wellness and weight management goals
BPC 157 stabilizes GABA neurotransmitters, helping with withdrawals and tolerance of certain drugs and also decreasing anxiety